Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print October 24, 2002, 10.1148/radiol.2253011564

(Radiology 2002;225:815.)

A more recent version of this article appeared on December 1, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boehm, T.
Right arrow Articles by Kaiser, W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boehm, T.
Right arrow Articles by Kaiser, W. A.

Radio-frequency Ablation of VX2 Rabbit Tumors: Assessment of Completeness of Treatment by Using Contrast-enhanced Harmonic Power Doppler US1

Thomas Boehm, MD, Ansgar Malich, MD, S. Nahum Goldberg, MD, Peter Hauff, DVM, PhD, Michael Reinhardt, Juergen R. Reichenbach, PhD, Wolfgang Müller, PhD, Marlies Fleck, MD, Burkhardt Seifert, PhD and Werner A. Kaiser, MD

1 From the Institute of Diagnostic Radiology, University Hospital Zurich, Rämistrasse 100, CH-8091 Zurich, Switzerland (T.B.); Institute of Diagnostic and Interventional Radiology, Friedrich-Schiller-University Jena, Germany (A.M., J.R.R., M.F., W.A.K.); Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass (S.N.G., P.H., M.R.); Research Laboratories, Schering, Berlin, Germany (P.H., M.R.); Berchtold, Tuttlingen, Germany (W.M.); and Department of Biostatistics, Institute of Social and Preventive Medicine, University of Zurich, Switzerland (B.S.). Received September 20, 2001; revision requested November 23; revision received February 15, 2002; accepted April 15. Address correspondence to T.B. (e-mail: thomas_boehm@gmx.net).



View larger version (64K):

[in a new window]
 
Figure 1. Gray-scale coronal US images (upper right and left and lower left images) of four retroperitoneally implanted VX2 tumors clearly show the outer borders (arrows) of the tumors. Necrotic areas (N) are seen in a larger tumor. Contrast-enhanced harmonic power Doppler US image (lower right image) obtained before ablation shows central (arrowhead) and peripheral (arrows) vascularity. Inset diagrams show plane and direction of view of each image.

 


View larger version (57K):

[in a new window]
 
Figure 2. Coronal US images of one tumor in a single animal obtained during RF ablation. Contrast-enhanced color Doppler US image (A) and contrast-enhanced harmonic power Doppler US image (B) obtained before ablation show intense central (arrowhead in A) and peripheral (arrows) vascular enhancement. Ablation was initiated immediately after the needle (arrowheads in C) was positioned. Fundamental B-mode US image (D) obtained shortly before the end of RF ablation shows an ill-defined hyperechoic lesion (arrows) obscuring the ablation needle, the ablated tumor, and a wide range of surrounding fatty tissue. Contrast-enhanced color Doppler US image (E) obtained after ablation shows no residual perfusion, and contrast-enhanced harmonic power Doppler US image (F) obtained after ablation shows a small area of residual perfusion (arrow). Ablation in this tumor was later found to be incomplete at histopathologic examination. Inset diagrams show plane and direction of view of each image.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 2002 by the Radiological Society of North America.